Community corner: The ART of preventing HIV

Nature Medicine

Volumn 17, Issue 1, 2011, Pages 46-47

  Mellors, John W ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; EMTRICITABINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MICROBICIDE; TENOFOVIR; ADENINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DEOXYCYTIDINE; DRUG DERIVATIVE; PHOSPHONIC ACID DERIVATIVE;

ANTIVIRAL RESISTANCE; ANUS INTERCOURSE; ARTICLE; CHEMOPROPHYLAXIS; CONDOM; DRUG EFFICACY; DRUG MONITORING; HEALTH CARE COST; HIGH RISK BEHAVIOR; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LIFE EXPECTANCY; NAUSEA; NEPHROTOXICITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PUBLIC HEALTH; SEROCONVERSION; SEXUAL BEHAVIOR; VIRUS REPLICATION; VIRUS TRANSMISSION; WEIGHT REDUCTION; ADULT; CIRCUMCISION; FEMALE; MALE; RANDOMIZATION; RISK ASSESSMENT;

ADENINE; ADULT; ANTI-HIV AGENTS; ANTI-RETROVIRAL AGENTS; CIRCUMCISION, MALE; DEOXYCYTIDINE; FEMALE; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; PHOSPHONIC ACIDS; RANDOM ALLOCATION; RISK ASSESSMENT;

EID: 84863739780     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm0111-46     Document Type: Article

References (9)

1. Grant, R. M. et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N. Engl. J. Med. published online, doi:10.1056/NEJMoa1011205 (23 November 2010).
2. Karim, Q. A. et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 329, 1168-1174, 2010.
3. Donnell, D. et al. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet 375, 2092-2098 (2010).
4. Gallant, J. E., Parish, M. A., Keruly, J. C. & Moore, R. D. Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment. Clin. Infect. Dis. 40, 1194-1198 (2005). (Pubitemid 40490248)
5. Golub, S. A., Kowalczyk, W., Weinberger, C. L. & Parsons, J. T. Preexposure prophylaxis and predicted condom use among highrisk men who have sex with men. J. Acquir. Immune Defic. Syndr. 54, 548-555 y (2010).
6. Mellors, J. W. Closing in on HIV-1: antiretroviral therapy back on track with HIV-1 protease inhibitors. Nat. Med. 2, 1-2 (1996).
7. Cohen, M. S., Hellmann, N., Levy, J. A., DeCock, K. & Lange, J. The spread, treatment, and prevention of HIV-1: evolution of a global pandemic. J. Clin. Invest. 118, 1244-1154 (2008).
8. Cohen, M. S., Gay, C., Kashuba, A. D., Blower, S. & Paxton, L. Narrative review: antiretroviral therapy to prevent the sexual transmission of HIV-1. Ann. Intern. Med. 146, 591-601 (2007). (Pubitemid 351650540)
9. Garcia-Lerma, J. G. et al. Intermittent prophylaxis with oral truvada protects macaques from rectal SHIV infect. Science Transl. Med. 13, 14ra4 (2010).